International Conference on Emerging Oncology, Liquid Biopsy & Biomarkers Practices

Important dates

1. 3 Dec

   Abstract / full paper deadline

   In 18 days

2. 30 Dec

   Conference

   Barcelona, Spain

All deadlines are as published by the organizer. Check the official website for the time zone.

About this conference

International Conference on Emerging Oncology, Liquid Biopsy & Biomarkers Practices ICEOLBBP is a leading international academic conference dedicated to advancing research, innovation, and global collaboration across science, engineering, technology, and interdisciplinary studies. Organized by Global Association for Scientific Research and Innovation, this prestigious event brings together researchers, scientists, academicians, industry professionals, and students from around the world to share groundbreaking ideas and explore the latest research trends. The conference provides a dynamic platform for presenting original research papers, participating in insightful keynote sessions, and engaging in technical discussions that address real-world challenges. Through its diverse program, International Conference On Emerging Oncology, Liquid Biopsy & Biomarkers Practices promotes innovation, knowledge exchange, and academic excellence across multiple disciplines. With a strong focus on global networking and research collaboration, International Conference on Emerging Oncology, Liquid Biopsy & Biomarkers Practices ICEOLBBP helps participants connect with international experts, build partnerships, and gain exposure to emerging technologies and scientific advancements. The event is designed to inspire impactful research contributions that shape the future of science, engineering, and innovation worldwide.

Topics and scope

• Medical Oncology
• Surgical Oncology
• Radiation Oncology
• Precision Oncology
• Translational Oncology
• Molecular Oncology
• Clinical Oncology
• Pediatric Oncology
• Hematologic Malignancies
• Solid Tumors
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Ovarian and Gynecologic Cancers
• Gastrointestinal Cancers
• Liver and Pancreatic Cancer
• Brain Tumors
• Rare Cancers
• Cancer Prevention and Screening
• Liquid Biopsy Technologies
• Circulating Tumor Cells (CTCs)
• Circulating Tumor DNA (ctDNA)
• Cell-Free DNA (cfDNA)
• Cell-Free RNA (cfRNA)
• Extracellular Vesicles and Exosomes
• Circulating Biomarkers
• Cancer Biomarker Discovery
• Molecular Diagnostics
• Genomic and Epigenomic Biomarkers
• Proteomic and Metabolomic Biomarkers
• Multi-Omics Biomarker Research
• Biomarker Validation
• Minimal Residual Disease (MRD)
• Companion Diagnostics
• Early Cancer Detection
• Molecular Pathology
• Cancer Genomics
• Pharmacogenomics
• Immuno-Oncology
• Cancer Immunotherapy
• Targeted Therapy
• Personalized Cancer Treatment
• Clinical Trials in Oncology
• Drug Resistance Mechanisms
• Cancer Monitoring and Prognosis
• AI-Assisted Cancer Diagnosis
• Digital Pathology
• Radiation Therapy Innovations
• Precision Medicine Applications
• Artificial Intelligence in Oncology
• Machine Learning for Cancer Prediction
• Bioinformatics and Computational Oncology
• Big Data Analytics in Cancer Research
• Digital Health and Oncology Informatics
• Wearable Technologies for Cancer Care
• Remote Patient Monitoring
• Nanotechnology in Cancer Diagnosis
• Regenerative Medicine
• Gene Editing and CRISPR Applications
• Translational Cancer Research
• Precision Diagnostics
• Future Trends in Oncology
• Future Trends in Liquid Biopsy
• Emerging Practices in Cancer Biomarker Research

Call for papers

Abstracts are due by 3 December 2026. Submission details are on the official website.